Home Newsfeeds Needham Downgrades InMode to Hold

Needham Downgrades InMode to Hold

Needham analyst Mike Matson downgrades InMode (NASDAQ:INMD) from Buy to Hold.

byBenzinga Newsdesk

February 17, 2023

1 minute read

Needham analyst Mike Matson downgrades InMode (NASDAQ:INMD) from Buy to Hold.

Nasdaq, S&P 500 Futures Edge Higher As Traders Bet On Fed Pause: Analyst Says Relief Rally Could Be In The Cards

By Shanthi Rexaline

September 20, 7:04 AM

US stocks await on Fed cues Wednesday amid the lean patch triggered by fears about inflation and in turn a 'higher for longer rate' outlook.

News

Digihost Increases Month Over Month BTC Output By 21%

By Benzinga Newsdesk

October 3, 5:32 AM

Digihost Technology Inc. ("Digihost" or the "Company") (NASDAQ:DGHI, TSXV:DGHI), an innovative U.S. based blockchain technology and computer infrastructure company, is pleased to provide unaudited

DGHI

Analyst Raises Bank Of America’s Price Target To $40, Yet Sees Higher Returns In Other US FIG Stocks

By Nabaparna Bhattacharya

October 18, 1:56 PM

BMO Capital Markets analyst James Fotheringham reiterated the Market Perform rating on Bank Of America Corporation (NYSE: BAC),

BAC

Evaxion Biotech, Pantherna Reveals Encouraging Data From mRNA-Based Cancer Vaccine

By Vandana Singh

February 8, 11:47 AM

Evaxion Biotech A/S (NASDAQ:EVAX) and Pantherna Therapeutics GmbH announced a preclinical proof of concept for combining the two companies key technologies. The…

EVAX

Needham Downgrades InMode to Hold

Related Posts

Nasdaq, S&P 500 Futures Edge Higher As Traders Bet On Fed Pause: Analyst Says Relief Rally Could Be In The Cards

Digihost Increases Month Over Month BTC Output By 21%

Analyst Raises Bank Of America’s Price Target To $40, Yet Sees Higher Returns In Other US FIG Stocks

Evaxion Biotech, Pantherna Reveals Encouraging Data From mRNA-Based Cancer Vaccine